Page last updated: 2024-11-02

pargyline and Muscular Dystrophies

pargyline has been researched along with Muscular Dystrophies in 2 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Muscular Dystrophies: A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sorato, E1
Menazza, S1
Zulian, A1
Sabatelli, P1
Gualandi, F1
Merlini, L1
Bonaldo, P1
Canton, M1
Bernardi, P1
Di Lisa, F1
Yu, MK1
Wright, TL1
Dettbarn, WD1
Olson, WH1

Other Studies

2 other studies available for pargyline and Muscular Dystrophies

ArticleYear
Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.
    Free radical biology & medicine, 2014, Volume: 75

    Topics: Adult; Apoptosis; Cells, Cultured; Child; Child, Preschool; Collagen Type VI; Humans; Hydrogen Perox

2014
Pargyline-induced myopathy with histochemical characteristics of Duchenne muscular dystrophy.
    Neurology, 1974, Volume: 24, Issue:3

    Topics: Acetylcholine; Adenosine Triphosphatases; Animals; Aorta, Abdominal; Biogenic Amines; Disease Models

1974